Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News EUDA Health Holdings Ltd EUDA

Alternate Symbol(s):  EUDAW

EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The company also provides property management services. The company is headquartered in Singapore.

Recent & Breaking News (NDAQ:EUDA)

EUDA Health Holdings Limited Announces Repurchase and Cancellation of Streeterville Warrant

GlobeNewswire 2 days ago

EUDA Health Announces Second Amendment to Streeterville Warrant Agreement

GlobeNewswire January 15, 2026

EUDA Enters into Convertible Loan Agreement with Shenzhen Inno, Further Expanding Stem Cell Therapy Platform

GlobeNewswire January 13, 2026

EUDA Health Holdings Limited Announces Amendment to Streeterville Warrant Agreement

GlobeNewswire January 7, 2026

EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital

GlobeNewswire December 30, 2025

EUDA Health to Launch EUDA Helixé 2.0 in January 2026

GlobeNewswire December 29, 2025

EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen

GlobeNewswire December 23, 2025

EUDA Integrates QB Utility Token to Create a Digital Health and Rewards Platform Across Its Healthcare Ecosystem

GlobeNewswire December 22, 2025

EUDA Plans to Integrate QB Utility Token into Its Healthcare Ecosystem

GlobeNewswire December 8, 2025

EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement

GlobeNewswire December 5, 2025

EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India

GlobeNewswire October 23, 2025

EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across Asia

GlobeNewswire October 20, 2025

EUDA Signs Letter of Intent to Potentially Acquire GO POSB

GlobeNewswire September 10, 2025

EUDA Strategically Expands into T-Cell Immunotherapy - Strengthening Its Stem Cell Therapy Portfolio

GlobeNewswire September 4, 2025

EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte Ltd

GlobeNewswire August 28, 2025

EUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health Supplement

GlobeNewswire August 26, 2025

EUDA Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia

GlobeNewswire April 24, 2025

EUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation

GlobeNewswire December 16, 2024

EUDA Health Holdings Limited Completes Acquisition of CK Health Plus Sdn Bhd, Expanding into Direct Selling Holistic Wellness Products in Southeast Asia

GlobeNewswire May 8, 2024

EUDA Health Expands into Direct Selling Holistic Wellness Products with Acquisition of CK Health

GlobeNewswire May 6, 2024